Sage Journals: Discover world-class research

Retricted access

Case report

First published 2023-6

Acute liver injury induced by drug interaction between dacomitinib and metoprolol due to the inhibition of CYP2D6 by dacomitinib

Xuejia Qiu, Bingnan Ren, Yufei Lian [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2018

Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer

Shuzo Tamura, Yin Wang, Brendan Veeneman [...]

Bladder Cancer

Free access

Review article

First published 2014-9

Novel agents in development for advanced non-small cell lung cancer

Thomas E. Stinchcombe

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2021-10

EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm,current evidence,and challenges

Arafat Tfayli, Razan Mohty

Tumori Journal

Open access

Research article

First published 2022

First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

Chongxiang Chen, Chunning Zhang, Huaming Lin [...]

Sage Open Chronic Disease

Open access

Review article

First published 2019

Second-line treatment of EGFR T790M-negative non-small cell lung cancer patients

Bin-Chi Liao, Sebastian Griesing, James Chih-Hsin Yang

Therapeutic Advances in Medical Oncology

Retricted access

Review article

First published 2023-6

New therapies in non-small cell lung cancer with EGFR exon 20 insertion mutations

Gil-Sierra Manuel David, Briceño-Casado Maria del Pilar, Moreno-Ramos Cristina

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2019

Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis

Zhonghan Zhang, Kangmei Zeng, Shen Zhao [...]

Therapeutic Advances in Medical Oncology

Search results